Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical pharmacology and therapeutics"
DOI: 10.1002/cpt.2439
Abstract: Tirabrutinib is an irreversible, small-molecule Bruton's tyrosine kinase (BTK) inhibitor, which was approved in Japan (VELEXBRU® ) to treat B-cell malignancies and is in clinical development for inflammatory diseases. As an application of model-informed drug…
read more here.
Keywords:
tirabrutinib;
semi mechanistic;
model;
btk ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Computer methods and programs in biomedicine"
DOI: 10.1016/j.cmpb.2020.105322
Abstract: BACKGROUND AND OBJECTIVE The aims of this study are (i) to assess the predictive reliability of the physiologically based software PhysPK versus the well-known population approach software NONMEM for the cited semi-mechanistic PK model, (ii)…
read more here.
Keywords:
modelling methodology;
methodology;
semi mechanistic;
physiologically based ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of environmental radioactivity"
DOI: 10.1016/j.jenvrad.2020.106467
Abstract: The aim of this study was to evaluate and improve the accuracy of the semi-mechanistic models used in regulatory exposure assessment tools, to describe the transfer factors of 137Cs from pasture soils to grass observed…
read more here.
Keywords:
mechanistic models;
term;
long term;
semi mechanistic ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14020246
Abstract: Antimicrobial resistance is a major public health issue. The pharmacokinetic/pharmacodynamic (PK/PD) model is an essential tool to optimize dosage regimens and alleviate the emergence of resistance. The semi-mechanistic PK/PD model is a mathematical quantitative tool…
read more here.
Keywords:
pharmacodynamic model;
pharmacokinetic pharmacodynamic;
semi mechanistic;
resistance ... See more keywords